Head and neck dermatitis: a variant of atopic dermatitis

被引:0
作者
Blicharz, Leszek [1 ]
Michalczyk, Agnieszka [1 ]
Maj, Malgorzata [1 ]
Czuwara, Joanna [1 ]
Olszewska, Malgorzata [1 ]
Rudnicka, Lidia [1 ]
机构
[1] Med Univ Warsaw, Dept Dermatol, Koszykowa 82A, PL-02008 Warsaw, Poland
关键词
Allergy; Dermatitis; atopic; Biological products; Malassezia; Janus kinase inhibitors; MOLLUSCUM CONTAGIOSUM; ECZEMA COXSACKIUM; ALOPECIA-AREATA; CONTACT-DERMATITIS; VIRAL-INFECTIONS; DOUBLE-BLIND; MALASSEZIA; DIAGNOSIS; SKIN; DUPILUMAB;
D O I
10.23736/S2784-8671.25.08001-6
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Atopic dermatitis involves the head and neck area across all age groups. This manifestation is frequently referred to as "the head and neck dermatitis." Aside from a considerable deterioration of the quality of life, it poses a significant diagnostic and therapeutic challenge. The head and neck dermatitis may be mimicked by other inflammatory conditions such as seborrheic dermatitis or contact dermatitis. Furthermore, it can be associated with a wide range of infectious, ocular, psychiatric and hair disorders, which should raise clinical alertness and encourage a multidisciplinary management of the affected individuals. Skin lesions in the head and neck area are often difficult to treat, particularly because of a considerable exposure of this region to exacerbating factors and limitations regarding the use of some pharmaceuticals. Although several hypotheses explaining the recalcitrant course of head and neck dermatitis have been proposed, none of them provide successful solutions applicable in the daily clinical practice. This comprehensive review comprises the current insights on the pathogenesis, clinical presentation, and comorbidities of the head and neck dermatitis. Recommendations regarding possible treatments of this condition such as antifungals, as well as special considerations for the choice of biologics or JAK inhibitors in the candidates for systemic treatment are outlined.
引用
收藏
页码:123 / 144
页数:22
相关论文
共 212 条
[11]   Efficacy and safety of switching from dupilumab to upadacitinib versus continuous upadacitinib in moderate-to-severe atopic dermatitis: Results from an open-label extension of the phase 3, randomized, controlled trial (Heads Up) [J].
Blauvelt, Andrew ;
Ladizinski, Barry ;
Prajapati, Vimal H. ;
Laquer, Vivian ;
Fischer, Alison ;
Eisman, Samantha ;
Hu, Xiaofei ;
Wu, Tianshuang ;
Calimlim, Brian M. ;
Kaplan, Blair ;
Liu, Yingyi ;
Teixeira, Henrique D. ;
Liu, John ;
Eyerich, Kilian .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) :478-485
[12]   Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis A Randomized Clinical Trial [J].
Blauvelt, Andrew ;
Teixeira, Henrique D. ;
Simpson, Eric L. ;
Costanzo, Antonio ;
De Bruin-Weller, Marjolein ;
Barbarot, Sebastien ;
Prajapati, Vimal H. ;
Lio, Peter ;
Hu, Xiaofei ;
Wu, Tianshuang ;
Liu, John ;
Ladizinski, Barry ;
Chu, Alvina D. ;
Eyerich, Kilian .
JAMA DERMATOLOGY, 2021, 157 (09) :1047-1055
[13]   Enterotoxin Gene Cluster and selX Are Associated with Atopic Dermatitis Severity-A Cross-Sectional Molecular Study of Staphylococcus aureus Superantigens [J].
Blicharz, Leszek ;
Zochowski, Maciej ;
Szymanek-Majchrzak, Ksenia ;
Czuwara, Joanna ;
Goldust, Mohamad ;
Skowronski, Krzysztof ;
Mlynarczyk, Grazyna ;
Olszewska, Malgorzata ;
Samochocki, Zbigniew ;
Rudnicka, Lidia .
CELLS, 2022, 11 (23)
[14]   The Influence of Microbiome Dysbiosis and Bacterial Biofilms on Epidermal Barrier Function in Atopic Dermatitis-An Update [J].
Blicharz, Leszek ;
Rudnicka, Lidia ;
Czuwara, Joanna ;
Waskiel-Burnat, Anna ;
Goldust, Mohamad ;
Olszewska, Malgorzata ;
Samochocki, Zbigniew .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)
[15]   The Propensity to Form Biofilm in vitro by Staphylococcus aureus Strains Isolated from the Anterior Nares of Patients with Atopic Dermatitis: Clinical Associations [J].
Blicharz, Leszek ;
Michalak, Maryla ;
Szymanek-Majchrzak, Ksenia ;
Mlynarczyk, Grazyna ;
Skowronski, Krzysztof ;
Rudnicka, Lidia ;
Samochocki, Zbigniew .
DERMATOLOGY, 2021, 237 (04) :528-534
[16]   Staphylococcus aureus: an underestimated factor in the pathogenesis of atopic dermatitis? [J].
Blicharz, Leszek ;
Rudnicka, Lidia ;
Samochocki, Zbigniew .
POSTEPY DERMATOLOGII I ALERGOLOGII, 2019, 36 (01) :11-17
[17]   Eczematous Drug Eruptions [J].
Blum, Amy E. ;
Burgin, Susan .
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2021, 22 (03) :349-366
[18]   Impact of dupilumab on patch test results and allergic contact dermatitis: A prospective multicenter study [J].
Bocquel, Sarah ;
Soria, Angele ;
Raison-Peyron, Nadia ;
Badaoui, Antoine ;
Marcant, Pierre ;
Bara, Corina ;
Giordano-Labadie, Francoise ;
Amsler, Emmanuelle ;
Milpied, Brigitte ;
Delaunay, Juliette ;
Darrigade, Anne-Sophie ;
Pralong, Pauline ;
Boulard, Claire ;
Bouedec, Marie-Christine Ferrier Le ;
Tauber, Marie ;
Pasteur, Justine ;
Valois, Aude ;
Le Thuaur, Aurelie ;
Crepy, Marie-Noelle ;
Bernier, Claire .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (03) :512-520
[19]   Tinea barbae (Tinea sycosis):: Experience with nine cases [J].
Bonifaz, A ;
Ramírez-Tamayo, T ;
Saúl, A .
JOURNAL OF DERMATOLOGY, 2003, 30 (12) :898-903
[20]   Erysipelas -: Recognition and management [J].
Bonnetblanc, JM ;
Bédane, C .
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2003, 4 (03) :157-163